Results
Camlin Fine Sciences Q1 FY27 EBITDA Drops to 4%
Camlin Fine Sciences reported Q1 FY27 revenue of INR5,199 million, up 28% YoY, but EBITDA margins collapsed to 4% from 45% due to high raw material costs and logistical issues.
Management revised full